ロード中...
NLRR1 Is a Potential Therapeutic Target in Neuroblastoma and MYCN-Driven Malignant Cancers
Receptor tyrosine kinases (RTKs) receive different modulation before transmitting proliferative signals. We previously identified neuronal leucine-rich repeat 1 (NLRR1) as a positive regulator of EGF and IGF-1 signals in high-risk neuroblastoma cells. Here, we show that NLRR1 is up-regulated in vari...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8279747/ https://ncbi.nlm.nih.gov/pubmed/34277416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.669667 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|